As of 13:36 on February 6, 2024, the CSI 1000 Index (000852) is strong**689%, the constituent stocks Ed Biotech and Wanxiang Technology have a daily limit. 1000 Enhanced ETF (561780)**697%, the latest price quoted at 08 yuan, and the intraday turnover has reached 994490,000 yuan, with a turnover rate of 4518%, the market is actively traded.
From a valuation perspective, the latest price-to-earnings ratio (PE-TTM) of the CSI 1000 Index tracked by the 1000 Enhanced ETF is only 1793 times, at 0 in the last 1 yearThe quantile of 4%, that is, the valuation is lower than 99 in the last 1 yearMore than 6% of the time, at an all-time low.
The 1000 Enhanced ETF closely tracks the CSI 1000 Index, which selects 1,000 smaller and more liquid ETFs** other than the CSI 800 Index sample as index samples, complementing the CSI 300 and CSI 500 indices.
According to the data, as of January 31, 2024, the top 10 weighted stocks of the CSI 1000 Index (000852) are Pacific (601099), Xinchao Energy (600777), Shenzhou Taiyue (300002), Huitai Medical (688617), Xingsen Technology (002436), O-film (002456), Runhe Software (300339), Jiangte Motor (002176), NavInfo (002405), Samsung Medical ( 601567), the top 10 weighted stocks accounted for 349%。
Minsheng** said: the seasonal effect is optimistic about the small market, but the risk of congestion still exists. Institutional attention continues to be biased, and the general trend perspective is more optimistic. In terms of congestion, small-cap congestion is currently close to the historical extreme level in 15 years. From the perspective of seasonal effects, the small-cap style in February is statistically significantly superior.
The above content and data have nothing to do with the position of the interface and do not constitute investment advice. Do so at your own risk.